Use
OwnerKerstin Uvnäs-Moberg, Thomas Lundeberginventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of substances with oxytocin for the preparation of pharmaceutical composition against inflamation. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against inflamation.
Claims18
A method for treating a subject suffering from or having an inflammation condition, comprising administering to said subject a substance with oxytocin activity.
Pharmaceutical composition against inflammation, characterised in that it comprises an effective concentration of at least one substance with oxytocin activity in mixture or otherwise together with at least one pharmaceutically acceptable carrier or excipient, wherein the substance is selected from the group consisting of the following compounds:
- X9 S
- X1-X2-X3-X4-Asn-Cys-X5-X6-X7-X8-NH2
- (SEQ ID NO:
- 2)
- wherein
- X1 is selected from the group consisting of Cys, Mpa and nothing,
- X2 is selected from the group consisting of Tyr, (O-methyl-Tyr), Phe, and nothing,
- X3 is selected from the group consisting of Ile, Val, Hoph, Phe, Cha, and nothing,
- X4 is selected from the group consisting of Gln, Ser, Thr, Cit, Arg, and Daba,
- X5 is selected from the group consisting of Pro, and nothing,
- X6 is selected from the group consisting of Ile, Leu, nothing, Val, Hos, Daba, Thr, Arg, and Cit,
- X7 is selected from the group consisting Gly, nothing, and Ala,
- X8 is selected from the group consisting Gly, and nothing,
- X9 is selected from the group consisting CH2 and S;
- as well as salts thereof.
Dependencies are inferred from the claim text.